The University of Iceland (Háskóli Íslands) in Reykjavik is the country's only medical school and one of the world's smallest — training approximately 48 medical students per year in an extraordinarily intimate learning environment. The six-year programme features clinical rotations exclusively at Landspítali (the National University Hospital of Iceland), a 600-bed hospital that is the sole tertiary referral centre for the entire nation. This creates a unique situation: students see virtually every complex case that occurs in a country of 380,000 people, gaining breadth of exposure that larger institutions cannot replicate.

The university's research strengths are extraordinary given Iceland's size: deCODE Genetics (now Amgen subsidiary) has leveraged Iceland's unique population genetics and comprehensive genealogical records to make breakthrough discoveries in cardiovascular disease, cancer, and neurological disorders. The medical faculty contributes to global knowledge of rare genetic conditions at rates far exceeding their population share. Reykjavik offers geothermal energy, stunning landscapes, midnight sun, northern lights, and one of the world's safest societies.

For UK students, Iceland represents a unique medical education model — though the programme is in Icelandic, the research environment is genuinely world-leading in human genetics.